Category: Conferences

ASCO GU 2026 Analyst Briefing: Webinar

Executive Summary: ONCrg analyst Sarah Lockheed previews four late-breaking phase 3 readouts at ASCO GU 2026 covering the post-CPI RCC setting, adjuvant RCC, and perioperative and advanced bladder cancer — all centered on belzutifan combinations and the continued expansion of the enfortumab vedotin plus pembrolizumab franchise.

ASCO GU 2026 Analyst Briefing

Pre-ASH 2025 Analyst Briefing: Webinar

Executive Summary: ONCrg analyst Patrick Nygren previews the highest-impact clinical presentations across hematologic malignancies at ASH 2025, covering CLL, multiple myeloma, NHL, and AML, with a focus on practice-changing phase 3 readouts and early-stage combination signals.

ESMO 25: Live Video Event, Analyst Briefing: ESMO – What to Watch in Breast Cancer

ONCrg breast cancer analyst Carla Cabrera, PhD reviews five potentially practice-changing phase 3 readouts from ESMO 2025, spanning early HER2-positive breast cancer, first-line triple-negative disease, and…

Pre-ESMO 2025 Analyst Briefing

Antibody Drug Conjugates

Medical Conference Coverage SNO: November 12-15, 2026 SABCS: December 8-11, 2026 ASH: December 12-15, 2026  ASCO GU: February 11-13, 2027 ELCC: March 17-20, 2027 SGO: March 19-22, 2027 AACR: April 2-7, 2027 ASCO: June 4-8, 2027 EHA: June 10-13, 2027 ICML: June 15-19, 2027 WCLC: September 11-14, 2027 ESMO: September 17-21, 2027 Antibody-Drug Conjugates (ADCs) […]

DNA Damage Response

The DNA damage response (DDR) field has seen major advances in recent years, particularly in ovarian, breast, prostate, and pancreatic cancers. Most cancers depend on DNA damage detection and repair for survival and are thus vulnerable to targeted inhibition of DDR proteins. DDR therapies include inhibitors of PARP, ATR, WEE1, and DNA-PK. The DDR field […]

Non-Hodgkin’s Lymphoma

Excerpt from Custom Post Type Indication: NHL

Myeloproliferative Neoplasms

Excerpt from Custom Post Type Indication: MPNs

Multiple Myeloma

Excerpt from Custom Post Type Indication: MM

    Sample Request

    How Did You Hear About Us